|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$80,369.80 |
2.35% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$79,884.63 |
2.33% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$79,463.31 |
2.32% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$78,911.94 |
2.30% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$77,091.84 |
2.25% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$77,163.46 |
2.25% |
| Steris Plc |
STE |
G8473T100 |
298 |
$76,368.46 |
2.23% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$76,150.26 |
2.22% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$75,776.26 |
2.21% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$74,652.96 |
2.18% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$74,005.68 |
2.16% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$73,704.76 |
2.15% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$73,640.49 |
2.15% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$73,464.03 |
2.14% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$72,660.87 |
2.12% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,250.50 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$71,458.80 |
2.09% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$71,695.62 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$71,709.41 |
2.09% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,964.19 |
2.07% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$70,459.00 |
2.06% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$70,164.18 |
2.05% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$70,239.65 |
2.05% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$70,395.74 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,192.73 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$69,617.87 |
2.03% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$69,195.18 |
2.02% |
| Waters Corporation |
WAT |
941848103 |
147 |
$69,222.30 |
2.02% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,696.92 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,475.21 |
2.00% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,222.28 |
1.99% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$67,879.03 |
1.98% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$67,550.00 |
1.97% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$67,559.61 |
1.97% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$67,401.98 |
1.97% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$67,213.89 |
1.96% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$66,356.25 |
1.94% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,311.34 |
1.94% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$65,673.75 |
1.92% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$64,609.23 |
1.89% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,474.90 |
1.88% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$64,555.31 |
1.88% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,344.00 |
1.88% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$62,876.97 |
1.84% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$61,062.22 |
1.78% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$59,570.44 |
1.74% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$58,804.86 |
1.72% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,250.36 |
1.61% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,547.99 |
1.30% |
| US Dollar |
$USD |
|
22,621 |
$22,620.50 |
0.66% |
| Japanese Yen |
$JPY |
|
165,348 |
$1,034.65 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|